USA flag logo/image

An Official Website of the United States Government

Calcium Phosphate Bone Cement Nanocomposites

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
93465
Program Year/Program:
2009 / SBIR
Agency Tracking Number:
AR056167
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
NANOVA, INC.
1005 BROOK TROUT CT COLUMBIA, MO -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2009
Title: Calcium Phosphate Bone Cement Nanocomposites
Agency: HHS
Contract: 1R43AR056167-01A1
Award Amount: $509,669.00
 

Abstract:

DESCRIPTION (provided by applicant): Calcium phosphate cements (CPCs) are used in orthopedic surgery as bone filler and have been proved with very good biocompatibility. However, the inadequate mechanical properties have significantly impeded their clinica l applications despite of the good biocompatibility. Nanova Inc. is developing novel bone cement nanocomposites containing super-strong and ultra-long hydroxyapatite (HA) fibers. It is hoped that the novel calcium phosphate cement nanocomposites will have excellent biocompatibility as well as sufficient mechanical properties as a bone implant materials for many orthopedic applications, such as general bone grafts, prosthesis fixation, plateau fracture fixation, vertebroplasty and kyphoplasty, etc. The curre nt prosthesis fixation using PMMA bone cements has a market of about 200 million. We believe that the calcium phosphate cements, if made strong and tough, will take over the current PMMA's market. Nanova Inc. estimated that the strong and tough calcium ph osphate cements may have a market over 1 billion based on our marketing analysis. The strong and tough calcium phosphate cement nanocomposites will benefit the millions of patients world wide and will be a major contribution for the healthcare in the Unit ed States. The knowledge gained in this high-impact and innovative research will benefit research in other fields, such as hard tissue engineering and other non-biomedical nanocomposites. PUBLIC HEALTH RELEVANCE: Nanova Inc. is developing calcium phosphat e bone cement nanocomposites containing hydroxyapatite (HA) fibers with significantly improved mechanical properties. Such nanocomposites have the following orthopedic applications, such as general bone grafts, prosthesis fixation, plateau fracture fixatio n, vertebroplasty, and kyphoplasty, and they will benefit millions of patients with bone fracture.

Principal Investigator:

Kenneth L. Lambert
5732346451
LAMBERTKENNETH@NANOVAMED.COM

Business Contact:

Meng Chen
lihao@nanovamed.com
Small Business Information at Submission:

NANOVA, INC.
1005 BROOK TROUT CT COLUMBIA, MO 65203

EIN/Tax ID: 126027436
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No